Our Company
TearLab Corporation is an in-vitro diagnostics company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
Corporate Background
TearLab Corporation launched The TearLab Osmolarity System for measuring tear film osmolarity in Germany, Spain, Italy, Ireland and the UK in October 2008. In addition, the product is now available in Turkey, Switzerland, Belgium, Luxembourg, France and The Netherlands as of January 2009. The Company is building a pipeline of other tests that can measure a range of clinically relevant protein biomarkers found in tears.
It is advised that you have the Macromedia flash plug in for optimal viewing experience.